ArticleOncotarget2016

Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.

Loredana Vesci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.